Report in English with a Dutch summary (KCE reports 45A)
Report in English with a Dutch summary (KCE reports 45A)
Report in English with a Dutch summary (KCE reports 45A)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>KCE</strong> <strong>reports</strong> vol.45 Screen<strong>in</strong>g for Colorectal Cancer 235<br />
335. Doolittle BR, Emanuel J, Tuttle C, Costa J. Detection of the mutated K-Ras<br />
biomarker <strong>in</strong> colorectal carc<strong>in</strong>oma. Experimental & Molecular Pathology.<br />
2001;70(3):289-301.<br />
336. Berger BM, Vucson BM, Diteberg JS. Gene mutations <strong>in</strong> advanced colonic polyps:<br />
potential marker selection for stool-based mutated human DNA assays for colon<br />
cancer screen<strong>in</strong>g. Cl<strong>in</strong>ical Colorectal Cancer. 2003;3(3):180-5.<br />
337. Boynton KA, Summerhayes IC, Ahlquist DA, Shuber AP. DNA <strong>in</strong>tegrity as a<br />
potential marker for stool-based detection of colorectal cancer. Cl<strong>in</strong>ical Chemistry.<br />
2003;49(7):1058-65.<br />
338. Chu E. The role of stool DNA analysis <strong>in</strong> the early detection and screen<strong>in</strong>g of<br />
colorectal cancer. Cl<strong>in</strong>ical Colorectal Cancer. 2003;3(1):9.<br />
339. Tagore KS, Lawson MJ, Yucaitis JA, Gage R, Orr T, Shuber AP, et al. Sensitivity and<br />
specificity of a stool DNA multitarget assay panel for the detection of advanced<br />
colorectal neoplasia. Cl<strong>in</strong>ical Colorectal Cancer. 2003;3(1):47-53.<br />
340. Calistri D, Rengucci C, Lattuneddu A, Francioni G, Polifemo AM, Nanni O, et al.<br />
Detection of colorectal cancer by a quantitative fluorescence determ<strong>in</strong>ation of DNA<br />
amplification <strong>in</strong> stool. Neoplasia (New York). 2004;6(5):536-40.<br />
341. Spethmann S, Fischer C, Wagener C, Streichert T, Tschentscher P. Nucleic acids<br />
from <strong>in</strong>tact epithelial cells as a target for stool-based molecular diagnosis of<br />
colorectal cancer. International Journal of Molecular Medic<strong>in</strong>e. 2004;13(3):451-4.<br />
342. Wu GH-M, Wang Y-M, Yen AM-F, Wong J-M, Lai H-C, Warwick J, et al. Costeffectiveness<br />
analysis of colorectal cancer screen<strong>in</strong>g <strong>with</strong> stool DNA test<strong>in</strong>g <strong>in</strong><br />
<strong>in</strong>termediate-<strong>in</strong>cidence countries. BMC Cancer. 2006;6(136).<br />
343. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. The Norwegian<br />
Colorectal Cancer Prevention (NORCCAP) screen<strong>in</strong>g study: basel<strong>in</strong>e f<strong>in</strong>d<strong>in</strong>gs and<br />
implementations for cl<strong>in</strong>ical work-up <strong>in</strong> age groups 50-64 years. Scand J<br />
Gastroenterol. 2003;38(6):635-42.<br />
344. Cotterchio M, Manno M, Klar N, McLaughl<strong>in</strong> J, Gall<strong>in</strong>ger S. Colorectal screen<strong>in</strong>g is<br />
associated <strong>with</strong> reduced colorectal cancer risk: a case-control study <strong>with</strong><strong>in</strong> the<br />
population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes<br />
Control. 2005;16(7):865-75.<br />
345. W<strong>in</strong>awer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, et al. A<br />
comparison of colonoscopy and double-contrast barium enema for surveillance after<br />
polypectomy. National Polyp Study Work Group. N Engl J Med. 2000;342(24):1766-<br />
72.<br />
346. Imperiale TF, Wagner DR, L<strong>in</strong> CY, Lark<strong>in</strong> GN, Rogge JD, Ransohoff DF. Risk of<br />
advanced proximal neoplasms <strong>in</strong> asymptomatic adults accord<strong>in</strong>g to the distal<br />
colorectal f<strong>in</strong>d<strong>in</strong>gs. N Engl J Med. 2000;343(3):169-74.<br />
347. Hardcastle J. Randomized control trial of faecal occult blood screen<strong>in</strong>g for colorectal<br />
cancer: results for the first 144,103 patients. Eur J Cancer Prev. 1991;1 Suppl<br />
2(21):21.<br />
348. Hardcastle JD, Chamberla<strong>in</strong> JO, Rob<strong>in</strong>son MH, Moss SM, Amar SS, Balfour TW, et<br />
al. Randomised controlled trial of faecal-occult-blood screen<strong>in</strong>g for colorectal<br />
cancer. Lancet. 1996;348(9040):1472-7.<br />
349. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O. Repeated screen<strong>in</strong>g for<br />
colorectal cancer <strong>with</strong> fecal occult blood test. A prospective randomized study at<br />
Funen, Denmark. Scand J Gastroenterol. 1989;24(5):599-606.<br />
350. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study<br />
of screen<strong>in</strong>g for colorectal cancer <strong>with</strong> faecal-occult-blood test. Lancet.<br />
1996;348(9040):1467-71.<br />
351. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screen<strong>in</strong>g for<br />
colorectal cancer us<strong>in</strong>g faecal occult blood test<strong>in</strong>g: results after 13 years and seven<br />
biennial screen<strong>in</strong>g rounds. Gut. 2002;50(1):29-32.